首页 > 最新文献

Lancet Regional Health-Americas最新文献

英文 中文
Economic burden of Chagas disease in Latin American countries: a population-based cost-of-illness analysis from the RAISE study 拉丁美洲国家恰加斯病的经济负担:来自RAISE研究的基于人群的疾病成本分析
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-20 DOI: 10.1016/j.lana.2025.101340
Mônica Viegas Andrade , Kenya Valeria Micaela de Souza Noronha , Aline de Souza , Nayara Abreu Julião , André Soares Motta-Santos , Paulo Estevão Franco Braga , Henrique Bracarense , André Batista Alves do Santos , Bruno Ramos Nascimento , Ísis Eloah Machado , Francisco Rogerlândio Martins-Melo , Israel Molina , Pablo Perel , Yvonne Geissbühler , Caroline Demacq , Hector Eduardo Castro Jaramillo , Luis Eduardo Echeverría , Mario Bruno Principato , Luisa Fernanda Aguilera Mora , Marisa Liliana Fernandez , Antonio Luiz Pinho Ribeiro

Background

Chagas disease (ChD) remains a public health concern in Latin America. Despite a decline in overall prevalence, the chronic symptomatic forms still impose a substantial epidemiological and economic burden. This study undertakes a comprehensive, population-based cost analysis of chronic Chagas disease (CCD) from a societal perspective in seven endemic Latin American countries for 2010 and 2023.

Methods

A Markov model with one-year cycles and six states was employed. Direct medical and indirect costs, converted to 2024 purchasing power parity US dollars, were estimated using prevalence data from the Global Burden of Disease Study 2023. Based on a previous Brazilian Markov model, parameters were adjusted using healthcare coverage and per capita health expenditure ratios for each country, further validated by national experts.

Findings

In 2010, Brazil (US$252 billion) and Argentina (US$164 billion) had the highest lifetime burdens. As a percentage of annual Gross Domestic Product, Bolivia (0·9%) and Argentina (0·8%) were most affected. CCD accounted for 6% of total health expenditures in both countries. Between 2010 and 2023, most countries experienced a decline in economic burden due to decreased CCD prevalence, despite an increased proportion of patients with cardiac conditions, reflecting population aging and disease progression.

Interpretation

CCD imposes substantial economic burden across Latin American countries. Epidemiological shift to older populations with severe cardiac forms signals increased healthcare demands. Findings inform policymakers for resource allocation and tailored interventions.

Funding

Funding was provided by Novartis Pharma AG as part of a research collaboration with the World Heart Federation (project number CLCZ696D2010R).
恰加斯病(ChD)仍然是拉丁美洲的一个公共卫生问题。尽管总体流行率有所下降,但慢性症状形式仍然造成重大的流行病学和经济负担。本研究从社会角度对2010年和2023年拉丁美洲七个流行国家的慢性恰加斯病(CCD)进行了全面的、基于人群的成本分析。方法采用1年周期、6个状态的马尔可夫模型。使用《2023年全球疾病负担研究》的患病率数据估算了转换为2024年购买力平价美元的直接医疗和间接成本。基于先前的巴西马尔可夫模型,使用每个国家的医疗保健覆盖率和人均医疗支出比率来调整参数,并由国家专家进一步验证。2010年,巴西(2520亿美元)和阿根廷(1640亿美元)的终生负担最高。作为年度国内生产总值的百分比,玻利维亚(0.9%)和阿根廷(0.8%)受到的影响最大。在这两个国家,CCD占卫生总支出的6%。2010年至2023年期间,尽管患有心脏病的患者比例增加,但由于CCD患病率下降,大多数国家的经济负担有所下降,这反映出人口老龄化和疾病进展。ccd给拉丁美洲国家带来了巨大的经济负担。流行病学向患有严重心脏疾病的老年人群转移表明医疗保健需求增加。研究结果为决策者提供了资源分配和量身定制干预措施的信息。资金由诺华制药公司提供,作为与世界心脏联合会研究合作的一部分(项目编号CLCZ696D2010R)。
{"title":"Economic burden of Chagas disease in Latin American countries: a population-based cost-of-illness analysis from the RAISE study","authors":"Mônica Viegas Andrade ,&nbsp;Kenya Valeria Micaela de Souza Noronha ,&nbsp;Aline de Souza ,&nbsp;Nayara Abreu Julião ,&nbsp;André Soares Motta-Santos ,&nbsp;Paulo Estevão Franco Braga ,&nbsp;Henrique Bracarense ,&nbsp;André Batista Alves do Santos ,&nbsp;Bruno Ramos Nascimento ,&nbsp;Ísis Eloah Machado ,&nbsp;Francisco Rogerlândio Martins-Melo ,&nbsp;Israel Molina ,&nbsp;Pablo Perel ,&nbsp;Yvonne Geissbühler ,&nbsp;Caroline Demacq ,&nbsp;Hector Eduardo Castro Jaramillo ,&nbsp;Luis Eduardo Echeverría ,&nbsp;Mario Bruno Principato ,&nbsp;Luisa Fernanda Aguilera Mora ,&nbsp;Marisa Liliana Fernandez ,&nbsp;Antonio Luiz Pinho Ribeiro","doi":"10.1016/j.lana.2025.101340","DOIUrl":"10.1016/j.lana.2025.101340","url":null,"abstract":"<div><h3>Background</h3><div>Chagas disease (ChD) remains a public health concern in Latin America. Despite a decline in overall prevalence, the chronic symptomatic forms still impose a substantial epidemiological and economic burden. This study undertakes a comprehensive, population-based cost analysis of chronic Chagas disease (CCD) from a societal perspective in seven endemic Latin American countries for 2010 and 2023.</div></div><div><h3>Methods</h3><div>A Markov model with one-year cycles and six states was employed. Direct medical and indirect costs, converted to 2024 purchasing power parity US dollars, were estimated using prevalence data from the Global Burden of Disease Study 2023. Based on a previous Brazilian Markov model, parameters were adjusted using healthcare coverage and per capita health expenditure ratios for each country, further validated by national experts.</div></div><div><h3>Findings</h3><div>In 2010, Brazil (US$252 billion) and Argentina (US$164 billion) had the highest lifetime burdens. As a percentage of annual Gross Domestic Product, Bolivia (0·9%) and Argentina (0·8%) were most affected. CCD accounted for 6% of total health expenditures in both countries. Between 2010 and 2023, most countries experienced a decline in economic burden due to decreased CCD prevalence, despite an increased proportion of patients with cardiac conditions, reflecting population aging and disease progression.</div></div><div><h3>Interpretation</h3><div>CCD imposes substantial economic burden across Latin American countries. Epidemiological shift to older populations with severe cardiac forms signals increased healthcare demands. Findings inform policymakers for resource allocation and tailored interventions.</div></div><div><h3>Funding</h3><div>Funding was provided by <span>Novartis Pharma AG</span> as part of a research collaboration with the <span>World Heart Federation</span> (project number CLCZ696D2010R).</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"54 ","pages":"Article 101340"},"PeriodicalIF":7.0,"publicationDate":"2025-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145790536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of eggs on Maya child development and growth: the Saqmolo’ Project randomized clinical trial 鸡蛋对玛雅儿童发育和生长的影响:Saqmolo项目随机临床试验
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-20 DOI: 10.1016/j.lana.2025.101339
Gabriela Montenegro-Bethancourt , Gabriela V. Proaño , Elizabeth Yakes Jimenez , Taylor C. Wallace , Alison Steiber , Xingya Ma , Ming Ji , Peter Rohloff

Background

There is worldwide interest in determining whether frequent egg provision during complementary feeding enhances child development and growth in low-resource settings. We evaluated effects of adding one whole egg per day to local standard nutrition care on infant outcomes.

Methods

The Saqmolo’ Project individually randomized, partially blinded, comparative effectiveness clinical trial was conducted in rural Guatemala from 2021 to 2023. Maya infants aged 6–9 months were randomized to standard nutrition care alone (growth monitoring, complementary and responsive feeding education, deworming medication, multiple micronutrient powders, and referrals for medical care) versus standard care plus one whole egg per day for 6 months. Mixed linear or logistic regression models were used to estimate between-group differences in primary (global development score) and secondary (growth, anemia status, and diet quality) outcomes.

Findings

This trial included 1200 Maya infants (51.3% male). After adjustment for baseline values and participant characteristics, there was no significant between-group difference in global development score (β −0.08 points [95% CI −0.22 to 0.06]). There were also no significant between-group differences for most secondary outcomes. Intervention participants did have significantly higher odds of stunting (odds ratio [OR] 1.42 [95% CI 1.10–1.82]; p = 0.007) and of meeting minimum dietary diversity (OR 1.41 [95% CI 1.20–1.65]; p < 0.001) and minimum adequate diet (OR 1.44 [95% CI 1.26–1.64]; p < 0.001) benchmarks than standard care participants.

Interpretation

Provision of one whole egg per day in addition to standard care improved diet quality but did not benefit development, growth, or anemia status among Maya infants.

Funding

Academy of Nutrition and Dietetics Foundation via an Egg Nutrition Center investigator-initiated research grant.
在低资源环境下,确定补充喂养期间频繁提供鸡蛋是否能促进儿童发育和生长,是全世界都感兴趣的问题。我们评估了在当地标准营养护理中每天添加一个全蛋对婴儿结局的影响。方法于2021 - 2023年在危地马拉农村地区进行Saqmolo项目随机、部分盲法临床试验。6 - 9个月的玛雅婴儿被随机分配到单独的标准营养护理组(生长监测、补充和反应性喂养教育、驱虫药物、多种微量营养素粉末和转诊医疗护理组)和标准护理组,每天加一个完整的鸡蛋,持续6个月。使用混合线性或逻辑回归模型来估计主要(总体发展评分)和次要(生长、贫血状况和饮食质量)结局的组间差异。该试验包括1200名玛雅婴儿(51.3%为男性)。调整基线值和参与者特征后,总体发展评分组间无显著差异(β - 0.08分[95% CI - 0.22 - 0.06])。在大多数次要结果方面,组间也没有显著差异。与标准护理参与者相比,干预参与者发育迟缓的几率(比值比[OR] 1.42 [95% CI 1.10-1.82]; p = 0.007)、满足最低饮食多样性(比值比[OR] 1.41 [95% CI 1.20-1.65]; p < 0.001)和最低适当饮食(比值比[OR] 1.44 [95% CI 1.26-1.64]; p < 0.001)的几率明显更高。解释:除了标准护理外,每天提供一个全蛋改善了玛雅婴儿的饮食质量,但对发育、生长或贫血状况没有好处。营养与饮食学会基金会通过鸡蛋营养中心研究者发起的研究资助。
{"title":"Effect of eggs on Maya child development and growth: the Saqmolo’ Project randomized clinical trial","authors":"Gabriela Montenegro-Bethancourt ,&nbsp;Gabriela V. Proaño ,&nbsp;Elizabeth Yakes Jimenez ,&nbsp;Taylor C. Wallace ,&nbsp;Alison Steiber ,&nbsp;Xingya Ma ,&nbsp;Ming Ji ,&nbsp;Peter Rohloff","doi":"10.1016/j.lana.2025.101339","DOIUrl":"10.1016/j.lana.2025.101339","url":null,"abstract":"<div><h3>Background</h3><div>There is worldwide interest in determining whether frequent egg provision during complementary feeding enhances child development and growth in low-resource settings. We evaluated effects of adding one whole egg per day to local standard nutrition care on infant outcomes.</div></div><div><h3>Methods</h3><div>The Saqmolo’ Project individually randomized, partially blinded, comparative effectiveness clinical trial was conducted in rural Guatemala from 2021 to 2023. Maya infants aged 6–9 months were randomized to standard nutrition care alone (growth monitoring, complementary and responsive feeding education, deworming medication, multiple micronutrient powders, and referrals for medical care) versus standard care plus one whole egg per day for 6 months. Mixed linear or logistic regression models were used to estimate between-group differences in primary (global development score) and secondary (growth, anemia status, and diet quality) outcomes.</div></div><div><h3>Findings</h3><div>This trial included 1200 Maya infants (51.3% male). After adjustment for baseline values and participant characteristics, there was no significant between-group difference in global development score (β −0.08 points [95% CI −0.22 to 0.06]). There were also no significant between-group differences for most secondary outcomes. Intervention participants did have significantly higher odds of stunting (odds ratio [OR] 1.42 [95% CI 1.10–1.82]; p = 0.007) and of meeting minimum dietary diversity (OR 1.41 [95% CI 1.20–1.65]; p &lt; 0.001) and minimum adequate diet (OR 1.44 [95% CI 1.26–1.64]; p &lt; 0.001) benchmarks than standard care participants.</div></div><div><h3>Interpretation</h3><div>Provision of one whole egg per day in addition to standard care improved diet quality but did not benefit development, growth, or anemia status among Maya infants.</div></div><div><h3>Funding</h3><div><span>Academy of Nutrition and Dietetics Foundation</span> via an <span>Egg Nutrition Center investigator-initiated research</span> grant.</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"54 ","pages":"Article 101339"},"PeriodicalIF":7.0,"publicationDate":"2025-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145790569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing real-world evidence in Brazil: regulatory gaps and global lessons 在巴西推进现实证据:监管差距和全球经验教训
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-20 DOI: 10.1016/j.lana.2025.101344
Nélio Cézar de Aquino , Cadiele Oliana Reichert , Luis Alberto de Padua Covas Lage , Hebert Fabricio Culler , Felipe Santa Rosa Roitberg , Vanderson Rocha , Flávia Neves Rocha Alves , Juliana Pereira
Regulatory agencies are increasingly incorporating real-world data (RWD) and real-world evidence (RWE) into decision-making frameworks to complement randomized clinical trials. While some regions, such as the U.S. and EU, have developed structured approaches for RWE use, Brazil's regulatory environment remains comparatively limited. This study examines the status of RWE regulatory integration in Brazil through an analysis of normative documents, institutional publications, and selected case studies, using a comparative policy perspective. Although advances have been made in data standardization and the publication of technical guidelines, such as ANVISA's Guidance No. 64/2023, the practical use of RWE in regulatory processes is still nascent. Key challenges include fragmented data infrastructure, and limited intersectoral coordination. Addressing these gaps will require improved interoperability across health information systems, convergence of methodological standards, and sustained collaboration among regulatory authorities, academia, and data holders to enable consistent and scientifically robust use of RWE in the Brazilian context and, potentially, in other low- and middle-income countries.
监管机构越来越多地将真实世界数据(RWD)和真实世界证据(RWE)纳入决策框架,以补充随机临床试验。虽然美国和欧盟等一些地区已经为莱茵集团制定了结构化的方法,但巴西的监管环境仍然相对有限。本研究采用比较政策的视角,通过对规范性文件、机构出版物和选定案例研究的分析,考察了巴西RWE监管一体化的现状。尽管在数据标准化和技术指南(如ANVISA的第64/2023号指南)的出版方面取得了进展,但RWE在监管过程中的实际应用仍处于起步阶段。主要挑战包括分散的数据基础设施和有限的部门间协调。解决这些差距将需要改进卫生信息系统之间的互操作性,统一方法标准,以及监管当局、学术界和数据持有者之间的持续合作,以便在巴西以及可能在其他低收入和中等收入国家持续和科学地使用RWE。
{"title":"Advancing real-world evidence in Brazil: regulatory gaps and global lessons","authors":"Nélio Cézar de Aquino ,&nbsp;Cadiele Oliana Reichert ,&nbsp;Luis Alberto de Padua Covas Lage ,&nbsp;Hebert Fabricio Culler ,&nbsp;Felipe Santa Rosa Roitberg ,&nbsp;Vanderson Rocha ,&nbsp;Flávia Neves Rocha Alves ,&nbsp;Juliana Pereira","doi":"10.1016/j.lana.2025.101344","DOIUrl":"10.1016/j.lana.2025.101344","url":null,"abstract":"<div><div>Regulatory agencies are increasingly incorporating real-world data (RWD) and real-world evidence (RWE) into decision-making frameworks to complement randomized clinical trials. While some regions, such as the U.S. and EU, have developed structured approaches for RWE use, Brazil's regulatory environment remains comparatively limited. This study examines the status of RWE regulatory integration in Brazil through an analysis of normative documents, institutional publications, and selected case studies, using a comparative policy perspective. Although advances have been made in data standardization and the publication of technical guidelines, such as ANVISA's Guidance No. 64/2023, the practical use of RWE in regulatory processes is still nascent. Key challenges include fragmented data infrastructure, and limited intersectoral coordination. Addressing these gaps will require improved interoperability across health information systems, convergence of methodological standards, and sustained collaboration among regulatory authorities, academia, and data holders to enable consistent and scientifically robust use of RWE in the Brazilian context and, potentially, in other low- and middle-income countries.</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"55 ","pages":"Article 101344"},"PeriodicalIF":7.0,"publicationDate":"2025-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145792268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of urgent gastrointestinal-related procedures in Latin America (LATAM-URG): a prospective multicentre study 拉丁美洲紧急胃肠道相关手术的结果(LATAM-URG):一项前瞻性多中心研究
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-16 DOI: 10.1016/j.lana.2025.101336
Latam Collaborative Colorectal Surgery Consortium
<div><h3>Background</h3><div>Urgent abdominal operations represent a large proportion of surgical care and are associated with substantial morbidity and mortality. Evidence is scarce from low- and middle-income countries (LMICs), including Latin America (LA). The lack of regionally representative outcomes data hinders quality-improvement efforts and understanding of modifiable risk factors that could be targeted to improve urgent care.</div></div><div><h3>Methods</h3><div>We present results from a prospective, multicenter observational cohort study of urgent abdominal surgery conducted in 14 countries across Latin America between February and December 2024. Eligible participants were consecutive adults (≥18 years) undergoing urgent gastrointestinal operations at each site during a 6-week inclusion window. The primary outcome was 30-day mortality. Secondary outcomes were reoperation, readmission, time to discharge, and prolonged intensive care unit (ICU) stay (defined as >72 h). Bayesian time-to-event models and Bayesian logistic regression were used to estimate associations between the outcomes and pre-specified covariates (age, sex, obesity, center volume, Charlson Comorbidity Index, SOFA score, surgical approach, operative time, prior abdominal surgery, intraoperative complications).</div></div><div><h3>Findings</h3><div>A total of 1015 patients were included from 89 hospitals (mean age 58.3 years; 50.4% female and 49.6% male). The most common indications for surgery were intestinal obstruction (46.8%), perforation (23.4%), and abdominal abscess (9.6%). Overall 30-day mortality was 12.6% (128/1015) and one in three of these deaths occurred within 24 h of the index operation. Prolonged ICU stay occurred in 27.9% of patients, reoperation was required in 18.4% and readmission in 4.9%. Across all models, we consistently found an association between Charlson Comorbidity Index >3, SOFA score >3, and open surgical approach with higher odds or hazard of adverse postoperative outcomes, including death. Patients with SOFA >3 had substantially increased odds of prolonged ICU stay and higher hazard of reoperation and death. In contrast, open surgery was associated with longer hospitalization and more reoperations, as well as higher mortality.</div></div><div><h3>Interpretation</h3><div>This large multi-country cohort provides the first region-wide estimates of outcomes after urgent abdominal surgery in Latin America. Mortality remains high, with almost one-third of all deaths occurring in the first 24 h after surgery. Patients’ comorbidity burden, physiological derangement at presentation, and operative approach are all key determinants of outcome after urgent abdominal surgery. This evidence provides a baseline for quality-improvement efforts and highlights the urgent need for region-specific guidelines and protocols to standardize urgent surgical care across Latin America.</div></div><div><h3>Funding</h3><div>This study received no external f
背景:紧急腹部手术在外科护理中占很大比例,并与大量的发病率和死亡率相关。来自包括拉丁美洲在内的低收入和中等收入国家的证据很少。缺乏具有区域代表性的结果数据阻碍了质量改进工作和对可改变的风险因素的理解,这些因素可能是改善紧急护理的目标。方法:我们报告了一项前瞻性、多中心观察队列研究的结果,该研究于2024年2月至12月在拉丁美洲的14个国家进行了紧急腹部手术。符合条件的参与者是连续的成年人(≥18岁),在6周的纳入窗口期间在每个部位接受紧急胃肠手术。主要终点为30天死亡率。次要结果为再手术、再入院、出院时间和延长重症监护病房(ICU)住院时间(定义为72小时)。使用贝叶斯时间-事件模型和贝叶斯逻辑回归来估计结果与预先指定的协变量(年龄、性别、肥胖、中心容积、Charlson合并症指数、SOFA评分、手术入路、手术时间、既往腹部手术、术中并发症)之间的关联。结果89家医院共纳入1015例患者,平均年龄58.3岁,女性50.4%,男性49.6%。最常见的手术指征是肠梗阻(46.8%)、穿孔(23.4%)和腹部脓肿(9.6%)。总体30天死亡率为12.6%(128/1015),其中三分之一的死亡发生在指数手术后24小时内。延长ICU住院时间占27.9%,再次手术占18.4%,再入院占4.9%。在所有模型中,我们一致发现Charlson合并症指数和SOFA评分与开放式手术入路之间存在较高的术后不良结果(包括死亡)的几率或风险。SOFA >;3患者延长ICU住院时间的几率显著增加,再手术和死亡的风险较高。相比之下,开放手术与更长的住院时间、更多的再手术以及更高的死亡率相关。这个大型的多国队列提供了拉丁美洲紧急腹部手术后的第一个区域范围的结果估计。死亡率仍然很高,几乎三分之一的死亡发生在手术后的头24小时。患者的合并症负担、就诊时的生理紊乱和手术方式都是紧急腹部手术后预后的关键决定因素。这一证据为质量改进工作提供了基线,并强调迫切需要制定区域特异性指南和方案,以规范整个拉丁美洲的紧急外科护理。本研究未获得外部资助。所有中心都提供了实物资源,包括人员和数据收集基础设施。
{"title":"Outcomes of urgent gastrointestinal-related procedures in Latin America (LATAM-URG): a prospective multicentre study","authors":"Latam Collaborative Colorectal Surgery Consortium","doi":"10.1016/j.lana.2025.101336","DOIUrl":"10.1016/j.lana.2025.101336","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;Urgent abdominal operations represent a large proportion of surgical care and are associated with substantial morbidity and mortality. Evidence is scarce from low- and middle-income countries (LMICs), including Latin America (LA). The lack of regionally representative outcomes data hinders quality-improvement efforts and understanding of modifiable risk factors that could be targeted to improve urgent care.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;We present results from a prospective, multicenter observational cohort study of urgent abdominal surgery conducted in 14 countries across Latin America between February and December 2024. Eligible participants were consecutive adults (≥18 years) undergoing urgent gastrointestinal operations at each site during a 6-week inclusion window. The primary outcome was 30-day mortality. Secondary outcomes were reoperation, readmission, time to discharge, and prolonged intensive care unit (ICU) stay (defined as &gt;72 h). Bayesian time-to-event models and Bayesian logistic regression were used to estimate associations between the outcomes and pre-specified covariates (age, sex, obesity, center volume, Charlson Comorbidity Index, SOFA score, surgical approach, operative time, prior abdominal surgery, intraoperative complications).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Findings&lt;/h3&gt;&lt;div&gt;A total of 1015 patients were included from 89 hospitals (mean age 58.3 years; 50.4% female and 49.6% male). The most common indications for surgery were intestinal obstruction (46.8%), perforation (23.4%), and abdominal abscess (9.6%). Overall 30-day mortality was 12.6% (128/1015) and one in three of these deaths occurred within 24 h of the index operation. Prolonged ICU stay occurred in 27.9% of patients, reoperation was required in 18.4% and readmission in 4.9%. Across all models, we consistently found an association between Charlson Comorbidity Index &gt;3, SOFA score &gt;3, and open surgical approach with higher odds or hazard of adverse postoperative outcomes, including death. Patients with SOFA &gt;3 had substantially increased odds of prolonged ICU stay and higher hazard of reoperation and death. In contrast, open surgery was associated with longer hospitalization and more reoperations, as well as higher mortality.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Interpretation&lt;/h3&gt;&lt;div&gt;This large multi-country cohort provides the first region-wide estimates of outcomes after urgent abdominal surgery in Latin America. Mortality remains high, with almost one-third of all deaths occurring in the first 24 h after surgery. Patients’ comorbidity burden, physiological derangement at presentation, and operative approach are all key determinants of outcome after urgent abdominal surgery. This evidence provides a baseline for quality-improvement efforts and highlights the urgent need for region-specific guidelines and protocols to standardize urgent surgical care across Latin America.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Funding&lt;/h3&gt;&lt;div&gt;This study received no external f","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"54 ","pages":"Article 101336"},"PeriodicalIF":7.0,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145790568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health and economic burden of insomnia medications among older Americans: findings from the future elderly model 美国老年人失眠药物的健康和经济负担:来自未来老年模型的发现
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-12 DOI: 10.1016/j.lana.2025.101333
Christopher N. Kaufmann , Adam P. Spira , Chien-Yu Tseng , Emerson M. Wickwire
{"title":"Health and economic burden of insomnia medications among older Americans: findings from the future elderly model","authors":"Christopher N. Kaufmann ,&nbsp;Adam P. Spira ,&nbsp;Chien-Yu Tseng ,&nbsp;Emerson M. Wickwire","doi":"10.1016/j.lana.2025.101333","DOIUrl":"10.1016/j.lana.2025.101333","url":null,"abstract":"","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"53 ","pages":"Article 101333"},"PeriodicalIF":7.0,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145736321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The right to health: indigenous data sovereignty in Canada during and beyond the COVID-19 pandemic 健康权:2019冠状病毒病大流行期间和之后加拿大的土著数据主权
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-12 DOI: 10.1016/j.lana.2025.101335
Alya Govorchin , Maëve Leduc , Clifford G. Atleo , Dawn Hoogeveen , Irina Borgos , Lyana Patrick
The COVID-19 pandemic disproportionately impacted Indigenous Peoples in Canada, highlighting preexisting health inequities. These disparities were exacerbated by inadequate data management policies across Canadian governments, which contribute to inaccurate health information and access challenges for Indigenous Nations. Indigenous data sovereignty, which recognizes the right of Indigenous Peoples to govern their own data, has been identified as essential for achieving self-determination and improving health outcomes. We focus on British Columbia (BC) given its unique health and data governance structure with First Nations. This policy paper examines the challenges related to health data management that arose during COVID-19 in BC, and the regulatory barriers hindering Indigenous health equity. We present four policy recommendations that address data issues as a promising avenue to reducing health inequities in Canada. This includes supporting research by and with Indigenous Peoples, promoting ethical responsibilities of non-Indigenous researchers, implementing anti-racism policies, and adopting Indigenous data management frameworks.
2019冠状病毒病大流行对加拿大土著人民的影响不成比例,凸显了先前存在的卫生不平等现象。加拿大各政府数据管理政策的不完善加剧了这些差异,导致卫生信息不准确,土著民族面临获取挑战。土著数据主权承认土著人民有权管理自己的数据,已被确定为实现自决和改善健康成果的关键。我们的重点是不列颠哥伦比亚省,因为它与第一民族有着独特的健康和数据治理结构。本政策文件审查了卑诗省在COVID-19期间出现的与卫生数据管理相关的挑战,以及阻碍土著卫生公平的监管障碍。我们提出了四项政策建议,将数据问题作为减少加拿大卫生不平等的有希望的途径。这包括支持土著人民的研究和与土著人民的研究,促进非土著研究人员的道德责任,实施反种族主义政策,并采用土著数据管理框架。
{"title":"The right to health: indigenous data sovereignty in Canada during and beyond the COVID-19 pandemic","authors":"Alya Govorchin ,&nbsp;Maëve Leduc ,&nbsp;Clifford G. Atleo ,&nbsp;Dawn Hoogeveen ,&nbsp;Irina Borgos ,&nbsp;Lyana Patrick","doi":"10.1016/j.lana.2025.101335","DOIUrl":"10.1016/j.lana.2025.101335","url":null,"abstract":"<div><div>The COVID-19 pandemic disproportionately impacted Indigenous Peoples in Canada, highlighting preexisting health inequities. These disparities were exacerbated by inadequate data management policies across Canadian governments, which contribute to inaccurate health information and access challenges for Indigenous Nations. Indigenous data sovereignty, which recognizes the right of Indigenous Peoples to govern their own data, has been identified as essential for achieving self-determination and improving health outcomes. We focus on British Columbia (BC) given its unique health and data governance structure with First Nations. This policy paper examines the challenges related to health data management that arose during COVID-19 in BC, and the regulatory barriers hindering Indigenous health equity. We present four policy recommendations that address data issues as a promising avenue to reducing health inequities in Canada. This includes supporting research by and with Indigenous Peoples, promoting ethical responsibilities of non-Indigenous researchers, implementing anti-racism policies, and adopting Indigenous data management frameworks.</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"54 ","pages":"Article 101335"},"PeriodicalIF":7.0,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145737799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A randomised, double-blind, sham-controlled, 2×2 factorial trial of aerobic vs. non-aerobic exercise and motor cortex transcranial direct current stimulation in fibromyalgia: effects on clinical outcomes and descending pain modulation 一项随机、双盲、假对照、2×2因子试验:有氧与非有氧运动和运动皮质经颅直流刺激治疗纤维肌痛:对临床结果和下行疼痛调节的影响
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-12 DOI: 10.1016/j.lana.2025.101314
Felipe Fregni , Luis Castelo-Branco , Alejandra Cardenas-Rojas , Marianna Daibes , Fernanda MQ. Silva , Kevin Pacheco-Barrios , Guilherme J.M. Lacerda , Lucas Camargo , Anna Carolyna Gianlorenco , Wolnei Caumo

Background

Exercise is first-line therapy for fibromyalgia, but the superiority of aerobic vs. non-aerobic modalities is uncertain. Motor-cortex transcranial direct current stimulation (tDCS) may enhance descending pain inhibition. We tested the effects of exercise modality and tDCS on conditioned pain modulation (CPM) and clinical outcomes.

Methods

Double-blind, randomised 2 × 2 factorial trial in Boston, USA (2019–2024; allocation 1:1:1:1). Adults with fibromyalgia were assigned to aerobic + active tDCS, aerobic + sham, non-aerobic + active, or non-aerobic + sham. Participants completed 16 in-person sessions over 4 weeks, combining concurrent tDCS and exercise. The non-aerobic condition involved light treadmill walking matched for duration but below aerobic threshold (<40% HRmax). Primary outcomes were changes in CPM and temporal summation of pain (TSP) at week 6; secondary outcomes were pain, fatigue, sleep, quality of life, and depressive symptoms.

Findings

Of 116 participants (mean age 47.1 ± 11.9 years), 88.8% were female. Active tDCS improved CPM vs. sham (Cohen's d = 0.66; p = 0.015), independent of exercise modality, and showed a small, nonsignificant improvement in TSP (mean change −0.19 [95% CI –0.90, 0.51]). All groups showed moderate-to-large improvements in pain, fatigue, and quality of life (Cohen's d 0.60–0.92), with no added benefit from tDCS. Non-aerobic and aerobic exercise produced comparable symptom improvements. Greater age and lower body mass index (BMI) were associated with enhanced response. Changes in pain modulation were not mediated by short-term clinical changes.

Interpretation

Supervised aerobic and non-aerobic exercise produced meaningful short-term clinical improvements. Motor-cortex tDCS enhanced descending pain inhibition but did not add clinical benefit beyond exercise over 6 weeks.

Funding

National Institutes of health (R01 1R01AT009491-01A1).
运动是纤维肌痛的一线治疗方法,但有氧与非有氧方式的优势尚不确定。运动皮质经颅直流电刺激(tDCS)可增强下行疼痛抑制。我们测试了运动方式和tDCS对条件性疼痛调节(CPM)和临床结果的影响。方法在美国波士顿进行双盲、随机2 × 2因子试验(2019-2024年,分配1:1:1:1:1)。患有纤维肌痛的成人被分为有氧+活动tDCS、有氧+假、非有氧+活动或非有氧+假。参与者在4周内完成了16次面对面的训练,结合了并发tDCS和锻炼。非有氧条件包括轻度跑步机步行匹配持续时间,但低于有氧阈值(40% HRmax)。主要结局是第6周时CPM和时间累积疼痛(TSP)的变化;次要结局是疼痛、疲劳、睡眠、生活质量和抑郁症状。116例参与者(平均年龄47.1±11.9岁),88.8%为女性。与假手术相比,主动tDCS改善了CPM (Cohen’s d = 0.66; p = 0.015),与运动方式无关,TSP也有小幅无显著改善(平均变化- 0.19 [95% CI -0.90, 0.51])。所有组在疼痛、疲劳和生活质量方面都有中等到较大的改善(Cohen’s d 0.60-0.92), tDCS没有额外的益处。非有氧运动和有氧运动对症状的改善效果相当。年龄越大,身体质量指数(BMI)越低,反应越强。疼痛调节的改变不受短期临床变化的影响。有监督的有氧和非有氧运动产生了有意义的短期临床改善。运动皮质tDCS增强了下行疼痛抑制,但在超过6周的运动后没有增加临床益处。美国国立卫生研究院(R01 1R01AT009491-01A1)。
{"title":"A randomised, double-blind, sham-controlled, 2×2 factorial trial of aerobic vs. non-aerobic exercise and motor cortex transcranial direct current stimulation in fibromyalgia: effects on clinical outcomes and descending pain modulation","authors":"Felipe Fregni ,&nbsp;Luis Castelo-Branco ,&nbsp;Alejandra Cardenas-Rojas ,&nbsp;Marianna Daibes ,&nbsp;Fernanda MQ. Silva ,&nbsp;Kevin Pacheco-Barrios ,&nbsp;Guilherme J.M. Lacerda ,&nbsp;Lucas Camargo ,&nbsp;Anna Carolyna Gianlorenco ,&nbsp;Wolnei Caumo","doi":"10.1016/j.lana.2025.101314","DOIUrl":"10.1016/j.lana.2025.101314","url":null,"abstract":"<div><h3>Background</h3><div>Exercise is first-line therapy for fibromyalgia, but the superiority of aerobic vs. non-aerobic modalities is uncertain. Motor-cortex transcranial direct current stimulation (tDCS) may enhance descending pain inhibition. We tested the effects of exercise modality and tDCS on conditioned pain modulation (CPM) and clinical outcomes.</div></div><div><h3>Methods</h3><div>Double-blind, randomised 2 × 2 factorial trial in Boston, USA (2019–2024; allocation 1:1:1:1). Adults with fibromyalgia were assigned to aerobic + active tDCS, aerobic + sham, non-aerobic + active, or non-aerobic + sham. Participants completed 16 in-person sessions over 4 weeks, combining concurrent tDCS and exercise. The non-aerobic condition involved light treadmill walking matched for duration but below aerobic threshold (&lt;40% HRmax). Primary outcomes were changes in CPM and temporal summation of pain (TSP) at week 6; secondary outcomes were pain, fatigue, sleep, quality of life, and depressive symptoms.</div></div><div><h3>Findings</h3><div>Of 116 participants (mean age 47.1 ± 11.9 years), 88.8% were female. Active tDCS improved CPM vs. sham (Cohen's d = 0.66; p = 0.015), independent of exercise modality, and showed a small, nonsignificant improvement in TSP (mean change −0.19 [95% CI –0.90, 0.51]). All groups showed moderate-to-large improvements in pain, fatigue, and quality of life (Cohen's d 0.60–0.92), with no added benefit from tDCS. Non-aerobic and aerobic exercise produced comparable symptom improvements. Greater age and lower body mass index (BMI) were associated with enhanced response. Changes in pain modulation were not mediated by short-term clinical changes.</div></div><div><h3>Interpretation</h3><div>Supervised aerobic and non-aerobic exercise produced meaningful short-term clinical improvements. Motor-cortex tDCS enhanced descending pain inhibition but did not add clinical benefit beyond exercise over 6 weeks.</div></div><div><h3>Funding</h3><div>National Institutes of health (R01 1R01AT009491-01A1).</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"53 ","pages":"Article 101314"},"PeriodicalIF":7.0,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145736320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Residency growth in Mexico: expansion and alignment challenges 墨西哥的居民增长:扩张和调整挑战
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-12 DOI: 10.1016/j.lana.2025.101337
Mauricio Gonzalez-Urquijo
{"title":"Residency growth in Mexico: expansion and alignment challenges","authors":"Mauricio Gonzalez-Urquijo","doi":"10.1016/j.lana.2025.101337","DOIUrl":"10.1016/j.lana.2025.101337","url":null,"abstract":"","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"54 ","pages":"Article 101337"},"PeriodicalIF":7.0,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145737868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mapping the expressions and impacts of racism on health in Brazil: a scoping review 描绘种族主义对巴西健康的表现和影响:范围审查
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-11 DOI: 10.1016/j.lana.2025.101323
Priscila de Morais Sato , Fernanda Lopes , Sonora English , Silvana Oliveira da Silva , James Berson Lalane , Thilagawathi Abi Deivanayagam , Rute Ramos da Silva Costa , Elizângela Baré , Indira Ramos Gomes , Delan Devakumar
We conducted a scoping review to examine how racism affects the health of minoritized populations in Brazil. A comprehensive search was carried out, and identified articles underwent independent double screening. The 145 included studies consistently highlighted structural health inequities, with White advantage functioning as a protective factor. Institutional racism restricts healthcare access and availability, exacerbating minoritized populations’ vulnerability to violence and disease through discrimination and substandard care. Spatial segregation further exposes minoritized populations to harmful environmental conditions and limited infrastructure, while traditional and migrant communities experience marginalization, social isolation, increased disease exposure, and poorer livelihoods. Interpersonal racism negatively impacts mental and physical health across the lifespan, with gender and socioeconomic conditions intersecting and shaping these experiences. The study provides critical insights for practice, policy, and research by demonstrating how racism at multiple levels shapes health inequities in Brazil and by emphasizing the need for human rights-centred, redistributive interventions that promote justice, equity, and inclusive care for minoritized populations.
Funding: This publication was funded by Edital 02/2025—PRPPG/UFBA (Scientific Publications Support Program) and by the CNPq Productivity in Research Scholarship (process number 306359/2024-3).
我们进行了一项范围审查,以检查种族主义如何影响巴西少数民族人口的健康。进行了全面的搜索,并对确定的文章进行了独立的双重筛选。纳入的145项研究一致强调结构性健康不平等,白人优势起着保护因素的作用。制度性种族主义限制了医疗服务的获取和提供,通过歧视和不合格的护理,加剧了少数群体遭受暴力和疾病侵害的脆弱性。空间隔离进一步使少数群体面临有害的环境条件和有限的基础设施,而传统社区和移徙社区则面临边缘化、社会孤立、疾病风险增加和生计较差的问题。人际种族主义在整个生命周期中对身心健康产生负面影响,性别和社会经济条件相互交织并影响着这些经历。该研究为实践、政策和研究提供了重要见解,展示了多层次的种族主义如何影响巴西的卫生不平等,并强调需要以人权为中心的再分配干预措施,促进对少数群体的正义、公平和包容性护理。本出版物由编辑02/2025-PRPPG /UFBA(科学出版物支持计划)和CNPq研究生产力奖学金(进程号306359/2024-3)资助。
{"title":"Mapping the expressions and impacts of racism on health in Brazil: a scoping review","authors":"Priscila de Morais Sato ,&nbsp;Fernanda Lopes ,&nbsp;Sonora English ,&nbsp;Silvana Oliveira da Silva ,&nbsp;James Berson Lalane ,&nbsp;Thilagawathi Abi Deivanayagam ,&nbsp;Rute Ramos da Silva Costa ,&nbsp;Elizângela Baré ,&nbsp;Indira Ramos Gomes ,&nbsp;Delan Devakumar","doi":"10.1016/j.lana.2025.101323","DOIUrl":"10.1016/j.lana.2025.101323","url":null,"abstract":"<div><div>We conducted a scoping review to examine how racism affects the health of minoritized populations in Brazil. A comprehensive search was carried out, and identified articles underwent independent double screening. The 145 included studies consistently highlighted structural health inequities, with White advantage functioning as a protective factor. Institutional racism restricts healthcare access and availability, exacerbating minoritized populations’ vulnerability to violence and disease through discrimination and substandard care. Spatial segregation further exposes minoritized populations to harmful environmental conditions and limited infrastructure, while traditional and migrant communities experience marginalization, social isolation, increased disease exposure, and poorer livelihoods. Interpersonal racism negatively impacts mental and physical health across the lifespan, with gender and socioeconomic conditions intersecting and shaping these experiences. The study provides critical insights for practice, policy, and research by demonstrating how racism at multiple levels shapes health inequities in Brazil and by emphasizing the need for human rights-centred, redistributive interventions that promote justice, equity, and inclusive care for minoritized populations.</div><div>Funding: This publication was funded by Edital 02/2025—PRPPG/UFBA (<span>Scientific Publications Support Program</span>) and by the <span>CNPq Productivity in Research Scholarship</span> (process number 306359/2024-3).</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"54 ","pages":"Article 101323"},"PeriodicalIF":7.0,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145737867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Building a health system resilience framework: national, state, regional, and local perspectives 建立卫生系统复原力框架:国家、州、区域和地方视角
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-11 DOI: 10.1016/j.lana.2025.101334
Marco Antonio Catussi Paschoalotto , Eduardo Alves Lazzari , Rudi Rocha , Adriano Massuda , Marcia C. Castro
Health system resilience (HSR) is essential to sustaining equitable essential functions under acute and chronic stressors in decentralized systems. We developed and validated a Brazil-tailored HSR framework that distinguishes steady-state performance from resilience-specific capacities and assigns responsibilities across federal, state, regional, and municipal levels. Using a three-phase qualitative deductive–inductive approach with 48 international and national experts, we identified nine dimensions, 18 subdimensions, and 65 indicators that prioritise governance coherence, surge workforce strategies, emergency regulation, real-time monitoring, and access to critical technologies. The framework clarifies boundaries between general health system performance and adaptive, absorptive, and transformative functions, and specifies how managers can apply it in practice through structured scoping, mapping, scoring, prioritisation, planning, and monitoring steps. Although designed for Brazil's Unified Health System (SUS), the development logic generalises to other decentralised contexts with appropriate re-allocation of responsibilities and calibration to national financing rules. This policy-facing tool supports actionable resilience strengthening in complex, multi-level systems.
在分散的卫生系统中,卫生系统复原力对于在急性和慢性压力源下维持公平的基本功能至关重要。我们开发并验证了为巴西量身定制的高铁框架,该框架区分了稳定状态绩效和特定弹性能力,并在联邦、州、地区和市级之间分配了责任。我们与48位国际和国内专家一起,采用三阶段定性演绎法,确定了9个维度、18个子维度和65个指标,这些指标优先考虑治理一致性、激增劳动力战略、应急监管、实时监控和获得关键技术。该框架明确了一般卫生系统绩效与适应性、吸收性和变革性职能之间的界限,并规定了管理人员如何通过结构化的范围界定、绘图、评分、优先排序、规划和监测步骤在实践中应用该框架。虽然是为巴西的统一卫生系统(SUS)设计的,但发展逻辑可以推广到其他分散的情况下,适当地重新分配责任并根据国家融资规则进行校准。这一面向政策的工具支持在复杂的多层次系统中加强可操作的复原力。
{"title":"Building a health system resilience framework: national, state, regional, and local perspectives","authors":"Marco Antonio Catussi Paschoalotto ,&nbsp;Eduardo Alves Lazzari ,&nbsp;Rudi Rocha ,&nbsp;Adriano Massuda ,&nbsp;Marcia C. Castro","doi":"10.1016/j.lana.2025.101334","DOIUrl":"10.1016/j.lana.2025.101334","url":null,"abstract":"<div><div>Health system resilience (HSR) is essential to sustaining equitable essential functions under acute and chronic stressors in decentralized systems. We developed and validated a Brazil-tailored HSR framework that distinguishes steady-state performance from resilience-specific capacities and assigns responsibilities across federal, state, regional, and municipal levels. Using a three-phase qualitative deductive–inductive approach with 48 international and national experts, we identified nine dimensions, 18 subdimensions, and 65 indicators that prioritise governance coherence, surge workforce strategies, emergency regulation, real-time monitoring, and access to critical technologies. The framework clarifies boundaries between general health system performance and adaptive, absorptive, and transformative functions, and specifies how managers can apply it in practice through structured scoping, mapping, scoring, prioritisation, planning, and monitoring steps. Although designed for Brazil's Unified Health System (SUS), the development logic generalises to other decentralised contexts with appropriate re-allocation of responsibilities and calibration to national financing rules. This policy-facing tool supports actionable resilience strengthening in complex, multi-level systems.</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"54 ","pages":"Article 101334"},"PeriodicalIF":7.0,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145737800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Lancet Regional Health-Americas
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1